VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
33 hedge funds and large institutions have $9M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 28 → 33 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
33
Holding in Top 10
1
Calls
$327K
Puts
$31K
Top Buyers
| 1 | +$693K | |
| 2 | +$398K | |
| 3 | +$117K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.4K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$43K |
Top Sellers
| 1 | -$1M | |
| 2 | -$865K | |
| 3 | -$34.2K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$18.6K |
| 5 |
Millennium Management
New York
|
-$26 |